ArticleMolecular cancer therapeutics2016

MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival.

Marina Radoul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.